Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Neostigmine/Atropine Versus Lignocaine for Post-dural Puncture Headache
NCT06824025Phase 1Recruiting
- Sponsor
- Minia University
- Start
- Feb 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of neostigmine and lidocaine in post-dural puncture headache (PDPH) (3 arms), sponsored by Minia University. Primary endpoint: Visual Analog Scale at 120 hours. Started Feb 2025; status: recruiting.
02
Drugs
neostigminelidocaine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT06824025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824025.